Annual Cash & Cash Equivalents
$4.66M$3.91M+519.68%
Summary
- Current Value
- As of today, GRDN annual cash & cash equivalents is $4.66M, up +519.68% on
- Historical Performance
- GRDN annual cash & cash equivalents is down -68.96% over the past 3 years, and up +1594.55% over the past 5 years
- All-Time High Comparison
- GRDN annual cash & cash equivalents is currently -68.96% below its historical high of $15.01M set on
- 3-Year Low Comparison
- GRDN annual cash & cash equivalents is +667.71% above its 3-year low of $607.00K reached on an earlier date
- Sector Comparison
- GRDN annual cash & cash equivalents is higher than 18.93% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.66M | +519.7% | -69.0% | +1594.5% | +106.9% | |
| Quarterly Cash & Cash Equivalents | $36.49M | -2.0% | +6278.9% | – | +1520.2% | |
| Price | $30.32 | +50.7% | – | – | – | |
| Annual Current Assets | $151.99M | +17.3% | +35.9% | +68.7% | +87.1% | |
| Annual Total Liabilities | $185.32M | -12.3% | +1.5% | +32.9% | +62.9% | |
| Annual Working Capital | $7.86M | +193.5% | +2275.8% | +7184.7% | -50.7% | |
| Annual Net Income | -$71.03M | -288.3% | -350.8% | -426.7% | -583.9% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $4.66M | at high | |
| 5Y | $15.01M | -69.0% | |
| All | $15.01M | -69.0% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $607.00K | N/A | +667.7% |
| 5Y | $607.00K | +667.7% | |
| All | $275.00K | +1594.5% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $4.66M | +519.7% | |
| $752.00K | +23.9% | |
| $607.00K | -96.0% | |
| $15.01M | +132.8% |
| Year | Value | Change |
|---|---|---|
| $6.45M | +2,245.1% | |
| $275.00K | -87.8% | |
| $2.25M | - |
FAQ
What is the current annual cash & cash equivalents of GRDN?
As of today, GRDN annual cash & cash equivalents is $4.66M
What is 1-year change in GRDN annual cash & cash equivalents?
GRDN annual cash & cash equivalents is up +519.68% year-over-year
What is 3-year change in GRDN annual cash & cash equivalents?
GRDN annual cash & cash equivalents is down -68.96% over the past 3 years
How far is GRDN annual cash & cash equivalents from its all-time high?
GRDN annual cash & cash equivalents is currently -68.96% below its historical high of $15.01M set on December 1, 2021
How does GRDN annual cash & cash equivalents rank versus sector peers?
GRDN annual cash & cash equivalents is higher than 18.93% of companies in Healthcare sector
When is GRDN next annual earnings release?
The next annual earnings release for GRDN is on
Quarterly Cash & Cash Equivalents
$36.49M$17.67M+93.90%
Summary
- Current Value
- As of today, GRDN quarterly cash & cash equivalents is $36.49M, up +93.90% on
- Historical Performance
- GRDN quarterly cash & cash equivalents is down -1.97% year-over-year, and up +6278.85% over the past 3 years
- All-Time High Comparison
- GRDN quarterly cash & cash equivalents is currently -1.97% below its historical high of $37.22M set on
- 3-Year Low Comparison
- GRDN quarterly cash & cash equivalents is +6278.85% above its 3-year low of $572.00K reached on
- Sector Comparison
- GRDN quarterly cash & cash equivalents is higher than 42.82% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $36.49M | +93.9% | -2.0% | +6278.9% | – | |
| Annual Cash & Cash Equivalents | $4.66M | – | +519.7% | -69.0% | +1594.5% | |
| Price | $30.32 | +28.0% | +50.7% | – | – | |
| Quarterly Current Assets | $198.28M | +16.3% | +10.0% | +67.5% | – | |
| Quarterly Total Liabilities | $194.54M | +10.1% | -9.2% | +2.8% | – | |
| Quarterly Working Capital | $36.33M | +37.3% | +65.5% | +270.3% | – | |
| Quarterly Net Income | $9.59M | +8.7% | +109.1% | – | +399.3% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $36.49M | at high | |
| 3Y | $37.22M | -2.0% | |
| 5Y | $37.22M | -2.0% | |
| All | $37.22M | -2.0% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.66M | N/A | +683.0% |
| 3Y | $572.00K | +6278.9% | |
| 5Y | $572.00K | +6278.9% | |
| All | $275.00K | >+9999.0% |
Quarterly Cash & Cash Equivalents History
| Month | Value | Change |
|---|---|---|
| $36.49M | +93.9% | |
| $18.82M | +34.4% | |
| $14.00M | +200.4% | |
| $4.66M | -87.5% | |
| $37.22M | +2,320.1% |
| Month | Value | Change |
|---|---|---|
| $1.54M | +104.5% | |
| $752.00K | +12.4% | |
| $669.00K | +17.0% | |
| $572.00K | - |
FAQ
What is the current quarterly cash & cash equivalents of GRDN?
As of today, GRDN quarterly cash & cash equivalents is $36.49M
What is GRDN quarterly cash & cash equivalents most recent change?
GRDN quarterly cash & cash equivalents was up +93.90% on September 30, 2025
What is 1-year change in GRDN quarterly cash & cash equivalents?
GRDN quarterly cash & cash equivalents is down -1.97% year-over-year
How far is GRDN quarterly cash & cash equivalents from its all-time high?
GRDN quarterly cash & cash equivalents is currently -1.97% below its historical high of $37.22M set on September 30, 2024
How does GRDN quarterly cash & cash equivalents rank versus sector peers?
GRDN quarterly cash & cash equivalents is higher than 42.82% of companies in Healthcare sector
When is GRDN next earnings release?
The next earnings release for GRDN is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GRDN Official Website guardianpharmacy.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802255/000119312525274298/0001193125-25-274298-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802255/000119312525064082/0001193125-25-064082-index.htm
- GRDN Profile on Yahoo Finance finance.yahoo.com/quote/GRDN
- GRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/grdn